ZEEMA DANIEL: Open Payments
NPI 1710576673 · MISSOURI CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 37 payments from 9 companies in 2025. Trend: 2023 $558 · 2024 $1,059 · 2025 $877
Food & beverage: $697Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $262 |
| Novartis Pharmaceuticals Corporation | 9 | $155 |
| Regeneron Healthcare Solutions, Inc. | 2 | $120 |
| Janssen Biotech, Inc. | 1 | $100 |
| Amgen Inc. | 5 | $74 |
| Arcutis Biotherapeutics, Inc. | 2 | $49 |
| UCB, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $44 |
| Organon LLC | 1 | $28 |
Products named: RINVOQ, COSENTYX, DUPIXENT, SKYRIZI, TREMFYA, OTEZLA, Zoryve, Bimzelx.
Industry payments across TX — which companies pay providers there.
